Watchlist Price Alert

Atea Pharmaceuticals Inc. (AVIR)

NASDAQ: AVIR · Real-Time Price · USD

2.80

0.00 (0.00%)

At close: May 07, 2025, 12:20 PM

Atea Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-168.38M	-135.96M	-115.91M	121.19M	-10.95M	-14.03M	-9.06M
Depreciation & Amortization	416K	416K	260K	29K	19K	17K	17K
Stock-Based Compensation	51.77M	49.43M	46.72M	39.62M	7.46M	624K	414K
Other Working Capital	-7.68M	14.46M	-44.6M	-258.13M	301.37M	422K	815K
Other Non-Cash Items	-11.82M	33.11M	-5.46M	29.39M	13.8M	501K	538K
Deferred Income Tax	n/a	-48.56M	n/a	-29.39M	-13.8M	-501K	n/a
Change in Working Capital	-7.48M	16.16M	-46.59M	-247.84M	300.2M	579K	725K
Operating Cash Flow	-135.5M	-85.39M	-120.98M	-87M	296.73M	-12.81M	-7.91M
Capital Expenditures	n/a	n/a	-1.94M	-4K	-26K	-2K	-12K
Cash Acquisitions	n/a	n/a	453.47K	n/a	n/a	n/a	n/a
Purchase of Investments	-461.18M	-562.36M	-545.35M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	517.28M	602.66M	91.89M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-453.47K	n/a	n/a	n/a	n/a
Investing Cash Flow	56.1M	40.3M	-455.41M	-4K	-26K	-2K	-12K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	267K	257K	140K	n/a	n/a	n/a	27.48M
Financial Cash Flow	267K	257K	370K	1.47M	531.75M	-15K	27.48M
Net Cash Flow	-79.13M	-44.84M	-576.02M	-85.54M	828.46M	-12.83M	19.56M
Free Cash Flow	-135.5M	-85.39M	-122.92M	-87.01M	296.71M	-12.82M	-7.92M